Could dead donors provide Life-Saving bone marrow?

NCT ID NCT05589896

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early study is testing whether bone marrow from deceased donors can be safely used for transplants in people with blood cancers like leukemia and lymphoma. Twelve patients will receive the transplant along with chemotherapy or radiation. The main goal is to see if the new marrow starts making blood cells and to check for serious side effects over the first year.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

bone marrow from a deceased donor

What this could lead to

If successful, this could provide a new source of bone marrow for transplants, potentially helping more patients with blood cancers who lack a living donor.

What could go wrong

This is a very early, small trial (12 people) focused on safety. The approach may fail to engraft or cause serious side effects, and it's unknown if it will work as well as standard living-donor transplants.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBLASTIC LEUKEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute biphenotypic leukemia acute leukemia acute lymphoblastic leukemia acute myeloid leukemia acute undifferentiated leukemia B-cell chronic lymphocytic leukemia chronic myelogenous leukemia, BCR-ABL1 positive hematologic disorder Hodgkins lymphoma leukemia Leukemia, B-Cell Leukemia, Myelogenous, Chronic, BCR-ABL Positive lymphoma myelodysplastic syndrome myelodysplastic syndrome with excess blasts non-Hodgkin lymphoma Precursor Cell Lymphoblastic Leukemia-Lymphoma primary cutaneous T-cell non-Hodgkin lymphoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • City of Hope

    RECRUITING

    Duarte, California, 91010, United States

    Contact

  • Emory University - Winship Cancer Institute

    RECRUITING

    Atlanta, Georgia, 30322, United States

    Contact

  • Henry Ford Cancer Institute

    RECRUITING

    Detroit, Michigan, 48202, United States

    Contact

  • Methodist Hospital, Texas Transplant

    RECRUITING

    San Antonio, Texas, 78229, United States

    Contact

  • Moffitt Cancer Center

    RECRUITING

    Tampa, Florida, 33612, United States

    Contact

  • Oregon Health and Science University

    RECRUITING

    Portland, Oregon, 97239, United States

    Contact

  • St. David's South Austin Medical Center

    RECRUITING

    Austin, Texas, 78745, United States

    Contact

  • TriStar Bone Marrow Transplant

    RECRUITING

    Nashville, Tennessee, 37203, United States

    Contact

  • University of Utah - Huntsman Cancer Institute

    RECRUITING

    Salt Lake City, Utah, 84112, United States

    Contact